IXHL
Incannex Healthcare Ltd ADRNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$37.87M
P/E Ratio
—
EPS
$-23.50
Beta
2.73
52W High
$49.80
52W Low
$2.40
50-Day MA
$5.82
200-Day MA
$11.41
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
3.22
PEG Ratio
—
About Incannex Healthcare Ltd ADR
Incannex Healthcare Limited is engaged in the research, development and sale of medicinal cannabinoid products in Australia. The company is headquartered in Sydney, Australia.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-25.38M |
| Operating Margin | 0.00% |
| Return on Equity | -130.40% |
| Return on Assets | -37.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $6.13 |
| Price-to-Book | 0.55 |
| Price-to-Sales (TTM) | 7764.11 |
| EV/Revenue | 1654.74 |
| EV/EBITDA | -5.13 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $13.97M |
| Float | $10.69M |
| % Insiders | 10.56% |
| % Institutions | 2.89% |
Data last updated: 4/8/2026